Bariatric medicine is the branch of medicine focused on the causes, prevention, and treatment of obesity. It covers far more than surgery. The field combines lifestyle changes, behavioral therapy, medication, and, when necessary, surgical procedures to help people lose weight and improve the health conditions that come with it. Physicians in this field treat obesity as a chronic disease, not a personal failing, and tailor treatment based on how severe the weight issue is and what related health problems a person has.
What Bariatric Medicine Actually Covers
Many people associate the word “bariatric” exclusively with weight loss surgery, but the field is much broader. Medical management of obesity involves three main pillars: lifestyle modification, pharmacotherapy, and behavioral therapy, often used together. Surgery enters the picture only when those approaches haven’t produced enough results or when a person’s weight is severe enough to pose immediate health risks.
The core idea is that obesity drives dozens of other conditions. Type 2 diabetes, high blood pressure, sleep apnea, abnormal cholesterol, heart disease, and certain cancers all improve or resolve when weight comes down significantly. Data from the American Society for Metabolic and Bariatric Surgery shows that among surgical patients, 92% see remission of type 2 diabetes, 96% see resolution of obstructive sleep apnea, 75% see remission of high blood pressure, and 76% see improvement in abnormal cholesterol levels. Those numbers explain why the field treats weight loss not as a cosmetic goal but as a medical intervention for serious disease.
How Obesity Is Diagnosed and Staged
BMI is the starting point. A BMI of 25 to 29.9 is classified as overweight. A BMI of 30 to 34.9 is Class I obesity, 35 to 39.9 is Class II, and 40 or above is Class III (sometimes called severe or morbid obesity). But BMI alone doesn’t capture the full picture, which is why waist circumference plays a role too. The NIH uses thresholds of 88 cm (about 35 inches) for women and 102 cm (about 40 inches) for men as markers of elevated health risk, though these numbers vary by ethnicity. For example, thresholds for people of East Asian descent are lower, around 80 to 90 cm, reflecting different body compositions.
A bariatric evaluation typically includes bloodwork to check thyroid function, blood sugar control, vitamin levels (B12, folate, iron), a lipid panel, markers of inflammation, and liver function. Depending on your history, you may also get an EKG, a chest X-ray, a cardiac stress test, or an upper GI endoscopy. These tests help identify conditions that obesity may already be causing and guide which treatments make sense.
Lifestyle and Behavioral Approaches
Clinical guidelines recommend a daily caloric deficit of 500 to 750 calories as a starting point. For exercise, the benchmark is at least 150 minutes per week of moderate-intensity aerobic activity, ramping up to 200 to 300 minutes per week for people trying to maintain weight loss long term.
But calorie targets and exercise plans only work if someone can stick with them, which is where behavioral therapy comes in. Cognitive-behavioral therapy is one of the most common approaches. It helps people identify the thought patterns and emotional triggers behind overeating, then build practical skills like self-monitoring, stimulus control (changing the environment to reduce temptation), stress management, and goal setting using the SMART framework: specific, measurable, assignable, realistic, and time-related goals.
Motivational interviewing is another widely used technique. Rather than lecturing, a clinician helps you explore your own reasons for wanting to change, resolve mixed feelings about it, and build confidence that change is possible. Other approaches include acceptance-based therapy, which focuses on tolerating cravings and uncomfortable emotions without acting on them, and interpersonal therapy, which addresses relationship patterns that may contribute to unhealthy eating.
Medications Used in Bariatric Medicine
Medication is typically recommended for people with a BMI of 30 or above, or a BMI of 27 or above with weight-related health problems, who haven’t lost enough weight through lifestyle changes alone. Several classes of drugs are now available, and they work through different mechanisms.
The GLP-1 receptor agonists have become the most prominent category. Semaglutide and liraglutide both work by acting on appetite-regulating centers in the brain, reducing hunger and slowing the rate at which food leaves your stomach. Semaglutide is a weekly injection; liraglutide is daily. Tirzepatide goes a step further by activating two gut hormone receptors simultaneously, which tends to produce greater weight loss. It’s also a weekly injection.
Older options are still in use. One combination medication pairs an appetite suppressant with an anti-seizure drug that independently reduces cravings. Another combines two drugs that work on the brain’s reward and appetite systems to reduce food cravings. There’s also a pill that blocks about 30% of dietary fat absorption in the gut, though it tends to produce more modest results and can cause digestive side effects.
For a small subset of patients with rare genetic forms of obesity, where specific gene mutations disrupt the brain’s hunger-signaling pathway, a targeted medication exists that directly corrects that pathway. This is a niche treatment, but it illustrates how the field is moving toward more personalized approaches.
When Surgery Becomes the Recommendation
Surgery is generally considered for people with a BMI of 40 or above, or a BMI of 35 or above with a weight-related health condition like diabetes, when non-surgical methods haven’t been enough. For people with a BMI of 50 or above, surgery is typically recommended as a first-line treatment regardless of whether other approaches have been tried.
The two most common procedures are sleeve gastrectomy, which removes a large portion of the stomach, and Roux-en-Y gastric bypass, which creates a small stomach pouch and reroutes part of the intestine. Newer, less invasive options are gaining traction. Endoscopic sleeve gastroplasty mimics a sleeve gastrectomy without any incisions or permanent tissue removal, making it an option for people with Class I or II obesity. Single-anastomosis procedures that combine a sleeve with intestinal rerouting have shown results comparable to traditional gastric bypass with simpler surgical technique.
Surgery consistently outperforms non-surgical treatment for weight loss, blood sugar control, blood pressure, cholesterol, and overall cardiovascular risk. Success after surgery is most commonly defined as losing more than 50% of excess weight within one to two years. Weight regain is possible, though. It’s generally defined as gaining back more than 10 kg from your lowest post-surgery weight or seeing your BMI climb back above 35 after initially dropping below it.
Who Practices Bariatric Medicine
Bariatric medicine is practiced by physicians from a range of backgrounds, including internal medicine, family medicine, endocrinology, and surgery. In the United States, certification happens primarily through the American Board of Obesity Medicine (ABOM), which grants a diplomate credential to physicians who pass its exam. It’s worth noting that obesity medicine is not yet recognized as a formal subspecialty by the American Board of Medical Specialties, which means the certification exists somewhat outside the traditional pathway of residency-to-fellowship-to-board-certification that most specialties follow. There is ongoing discussion about whether and how to formalize it further, including the potential creation of accredited obesity medicine fellowships.
In practice, your bariatric care team often extends well beyond one physician. Registered dietitians, psychologists or therapists trained in behavioral approaches, exercise physiologists, and surgeons all play roles depending on which treatment path you’re on. The multidisciplinary model is central to how the field operates, reflecting the reality that obesity has biological, behavioral, and environmental dimensions that no single provider can address alone.